Publications

September 1996 (Revised December 1997)
Case

Cytec Industries' Spin-Off (A): Sink or Swim?

In the wake of market pressure to restructure, American Cyanamid spun off its poorly performing Chemicals Unit into a new publicly traded corporation, Cytec Industries. In addition to weak operations, Cytec inherited the bulk of Cyanamid's environmental and... View Details

Keywords: Organizational Change and Adaptation; Management Practices and Processes; Restructuring; Performance Improvement; Chemical Industry; United States

October 1994 (Revised January 1995)
Case

Rhone-Poulenc (A) and (B) Condensed

Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details

Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States

September 1993
Case

Rhone-Poulenc (B)

Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details

Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States

October 1990 (Revised April 1991)
Case

RU 486 (A)

By: Joseph L. Badaracco Jr.

Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details

Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Health Industry; Health Industry; France; Germany; United States

July 1997 (Revised April 1998)
Case

Chase Manhattan Corporation: The Making of America's Largest Bank

By: Stuart C. Gilson and Cedric Escalle

Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details

Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States

September 2011
Case

China Development Bank

By: Li Jin, Matthew Preble and Aldo Sesia

In May 2011, Chairman Chen Yuan of the China Development Bank (CDB) was thinking back on CDB's financing of a major project between Petroleo Brasileiro SA (Petrobras), Brazil's state-owned oil and gas producer and China Petroleum & Chemical Corporation (Sinopec), one... View Details

Keywords: International Finance; Emerging Markets; Energy Sources; Banks and Banking; Energy Industry; Brazil; China

2022
Article

Missing Novelty in Drug Development

By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou

We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We introduce a new measure of drug novelty based on chemical similarity and show that firms face a risk-reward trade-off: novel drug candidates are less likely to... View Details

Keywords: Drug Development; Risk Aversion; Research and Development; Innovation and Invention; Investment; Pharmaceutical Industry

March 2001
Article

Technological Acquisitions and the Innovation Performance of Acquiring Firms: A Longitudinal Study

By: Gautam Ahuja and Riitta Katila

This paper examines the impact of acquisitions on the subsequent innovation performance of acquiring firms in the chemicals industry. We distinguish between technological acquisitions, acquisitions in which technology is a component of the acquired firm's assets, and... View Details

Keywords: Innovation; Acquisitions; Knowledge; Strategy; Knowledge Acquisition; Acquisition; Innovation and Invention; Chemical Industry

December 2017 (Revised December 2018)
Case

OCP Group

By: Kristin Fabbe, Forest Reinhardt, Natalie Kindred and Alpana Thapar

This case explores the strategy of OCP Group, the 95% state-owned Moroccan firm charged with managing the North African country’s vast reserves of phosphate. Phosphate was one of the most vital macronutrients for plant health, along with nitrogen and potassium, and... View Details

Keywords: OCP; OCP Group; Casablanca; Chemicals; Operations; Transformation; Competitive Strategy; Competitive Advantage; Chemical Industry; Morocco

Article

The Evolution of Science-Based Business: Innovating How We Innovate

By: Gary P. Pisano

Science has long been connected to innovation and to business. As early as the late 19th century, chemical companies, realizing the commercial potential of science, created the first industrial research laboratories. During much of the 20th century, large-scale... View Details

Keywords: Entrepreneurship; Governance; Innovation and Management; Risk Management; Research and Development; Science-Based Business; Commercialization

Read Now

05 Jul 2006
Research & Ideas

The Accidental Innovator

Companies spend many hundreds of billions of dollars on R&D each year, but the microwave oven was conceived from a melted candy bar, saccharin from an accidental chemical spill, and the Daguerre photo process via a shattered... View Details

Keywords: by Sarah Jane Gilbert

January 1990 (Revised October 1993)
Case

Monsanto's March into Biotechnology (A)

By: Gary P. Pisano

Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional... View Details

Keywords: History; Transition; Biotechnology Industry; Biotechnology Industry

October 1992 (Revised August 1994)
Case

Allied-Signal: Managing the Hazardous Waste Liability Risk

By: Richard H.K. Vietor and Edward Prewitt

Allied-Signal, Inc., one of the world's oldest chemical companies and today a diversified conglomerate, is liable for clean-up costs of old hazardous waste sites. These costs are substantial: reserves grew to nearly $500 million in 1991. Attempting to avoid further... View Details

Keywords: Wastes and Waste Processing; Environmental Sustainability; Programs; Cost Management; Policy; Government Legislation; Factories, Labs, and Plants; Governance Compliance; Legal Liability; Chemical Industry; United States; Europe

January 1997 (Revised July 1998)
Case

Dendrite International (Condensed)

By: John A. Deighton

This version has been shortened to concentrate on the issue of managing a long selling process and long post-sale account relationship. The focus on the pharmaceutical industry in the United States, Europe, and Japan is preserved. Broader questions of expansion into... View Details

Keywords: Customer Focus and Relationships; Marketing Strategy; Product Development; Sales; Expansion; Chemical Industry; Chemical Industry; Japan; Europe; United States

07 Jan 2010
Working Paper Summaries

International Differences in the Size and Roles of Corporate Headquarters: An Empirical Examination

Keywords: by David Collis, David Young & Michael Goold

November 2003 (Revised March 2006)
Case

Dow Chemical's Bid for the Privatization of PBB in Argentina

By: Mihir A. Desai and Alexandra de Royere

What price should Dow Chemical bid for PBB, a petrochemical complex that is being privatized by the Argentine government? To answer this question, students are forced to consider the role of country risk, the underlying currency exposure of the business, and how to... View Details

Keywords: Bids and Bidding; Privatization; Credit Derivatives and Swaps; Cash Flow; Emerging Markets; Valuation; Business and Government Relations; Multinational Firms and Management; Risk and Uncertainty; Energy Industry; Argentina

2009
Article

Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era

By: Arthur A. Daemmrich

This article presents a case study of the rise of Pfizer as a leading pharmaceutical company, with a focus on changing relationships between manufacturing technology and R&D between the mid-1940s and the mid-1960s. Pfizer first moved into pharmaceuticals through... View Details

Keywords: Research and Development; Production; Technology; Transformation; Relationships; Success; Organizations; Programs; Chemicals; Alignment; Pharmaceutical Industry; United States

02 Apr 2019
Research Event

Women Pay a Higher Career Price in Today's Always-On Work Culture

Ely says. “In fact, there’s a lot of evidence to suggest that it’s going to undermine the quality of the work.” A chemical reaction When Ely’s team suggested to the consulting firm that its employees worked an unnecessary number of hours,... View Details

Keywords: by Danielle Kost; Consulting; Service

September 2013
Case

SafeBlend Fracturing

By: Benson P. Shapiro, Frank V. Cespedes and Alisa Zalosh

The CEO of SafeBlend Technologies must set a price for the company's environmentally friendly fracturing fluid additive. The firm is negotiating a new contract with its biggest client, Bristol Natural Gas. For the last two years, SafeBlend has been the sole provider of... View Details

Keywords: Information Technology; Customer Relationship Management; Price; Negotiation; Competitive Advantage; Environmental Sustainability; Energy Sources; Sales; Energy Industry